EDIT
Editas Medicine, Inc.
Latest Form 4:Sale$2KbyParison Amy (SVP, Chief Financial Officer) · filed Aug 5, 2026
Editas Medicine, Inc. (EDIT) has 11 SEC Form 4 filings (11 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Aug 5, 2026.
The most active filer is SVP, Chief Financial Officer Parison Amy with 4 filings.
- Industry:Biotechnology
- CEO:Gilmore O'Neill
- Employees:87
- HQ:Cambridge, MA, US
- IPO:2016-02-03
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$88K
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$506.8M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| SVP, Chief Financial Officer | Sale | 678 | $2K | Aug 5 | SEC ↗ | |
| EVP, CHIEF SCIENTIFIC OFFICER | Sale | 4,928 | $13K | Jul 29 | SEC ↗ | |
Burkly LindaFirst in 3 months | EVP, CHIEF SCIENTIFIC OFFICER | Sale | 731 | $2K | Jun 5 | SEC ↗ |
Parison AmyFirst in 3 months | SVP, Chief Financial Officer | Sale | 464 | $1K | Jun 5 | SEC ↗ |
O'Neill Gilmore NeilFirst in 3 months | CEO | Sale | 15,380 | $42K | Jun 5 | SEC ↗ |
O'Neill Gilmore NeilFirst in 3 months | CEO | Sale | 5,394 | $11K | Mar 4 | SEC ↗ |
Burkly LindaFirst in 3 months | EVP, CHIEF SCIENTIFIC OFFICER | Sale | 749 | $2K | Mar 4 | SEC ↗ |
Parison AmyFirst in 3 months | SVP, Chief Financial Officer | Sale | 474 | $957 | Mar 4 | SEC ↗ |
Burkly LindaFirst filing | EVP, CHIEF SCIENTIFIC OFFICER | Sale | 713 | $2K | Dec 4 | SEC ↗ |
Parison AmyFirst filing | SVP, Chief Financial Officer | Sale | 461 | $993 | Dec 4 | SEC ↗ |
O'Neill Gilmore NeilFirst filing | CEO | Sale | 5,603 | $12K | Dec 4 | SEC ↗ |
Related companies
Editas Medicine, Inc. is in the Healthcare sector.